CAWM
ARKG icon

Capital A Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Capital A Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-880
Closed -$18.3K – 445
2025
Q1 		$18.3K Sell
880
-1,651
-65% -$41.5K 0.02% 234
2024
Q4 		$59.6K Buy
+2,531
New +$62.3K 0.1% 146

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital A Wealth Management's ARKG Position: Q2 2025 in Review

Capital A Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 880 shares — an estimated $18.3K sold.

Capital A Wealth Management first reported a position in ARKG in Q4 2024 and held it in 2 quarters. The position peaked at $59.6K in Q4 2024. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

  • Capital A Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
  • Capital A Wealth Management sold 880 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $18.3K.
  • Capital A Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 2 quarters.
  • Capital A Wealth Management's ARK Genomic Revolution ETF position peaked at $59.6K in Q4 2024.
  • 213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Capital A Wealth Management's 13F filing for Q2 2025, filed 26 Sep 2025.